Top Industry News
- PMDA Safety Information for Drugs and Medical Devices
- New Zealand Clarifies Acceptable Overseas Evidence of GMP in Updated Medicine Guidelines
- ANVISA Regulates Import of Regularized Medical Devices
- India Puts Regulations that Facilitate R&D at Heart of New Policy on Pharma and Medtech
- Release of Food Safety and Standards (Alcoholic Beverages) First Amendment Regulations, 2023
- European Commission Publishes Flowchart for Understanding Rules on Legacy MDR Devices
- Health Canada Reviewing Tolfenpyrad: Public Input Needed for Proposed Maximum Residue Limit PMRL2023-40
- Notify the MHRA About a Clinical Investigation for a Medical Device
- PMDA - ICH S1B (R1) Guideline Information Session
- Malaysia Public Comment First Edition Guidance Document: Wearable Medical Device
- MHRA More Submissions - User Reference Guide
- MHRA More Registrations - User Reference Guide
- New Zealand Enacts Compulsory Folic Acid Fortification to Protect Infants from Birth Defects
- Malaysia-Directive Regarding the Addition of Warning Statements for Health Supplement Products Containing Chromium Active Ingredient
- URGENT NOTICE – OPSS Requests Information on Suspected Endocrine Disruptors
- CRITICAL NOTICE – OPSS Requests Data Regarding Nanomaterials
- Effective from August 11, 2023, the State of California Lists the Following Chemicals as Carcinogenic: Anthracene, 2-Bromopropane, and Dimethyl Hydrogen Phosphite